| pubmed-article:19414346 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19414346 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:19414346 | lifeskim:mentions | umls-concept:C1332002 | lld:lifeskim |
| pubmed-article:19414346 | lifeskim:mentions | umls-concept:C1122962 | lld:lifeskim |
| pubmed-article:19414346 | lifeskim:mentions | umls-concept:C1514762 | lld:lifeskim |
| pubmed-article:19414346 | lifeskim:mentions | umls-concept:C0205464 | lld:lifeskim |
| pubmed-article:19414346 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19414346 | pubmed:dateCreated | 2009-5-5 | lld:pubmed |
| pubmed-article:19414346 | pubmed:abstractText | It has been previously shown that gefitinib reverses breast cancer resistance protein (BCRP)-mediated drug resistance. Here, the impact of BCRP on gefitinib-mediated inhibition in epidermal growth factor receptor (EGFR) signaling is evaluated. | lld:pubmed |
| pubmed-article:19414346 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19414346 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19414346 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19414346 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19414346 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:19414346 | pubmed:author | pubmed-author:SugimotoYoshi... | lld:pubmed |
| pubmed-article:19414346 | pubmed:author | pubmed-author:NoguchiKohjiK | lld:pubmed |
| pubmed-article:19414346 | pubmed:author | pubmed-author:ShibataKazuhi... | lld:pubmed |
| pubmed-article:19414346 | pubmed:author | pubmed-author:KatayamaKazuh... | lld:pubmed |
| pubmed-article:19414346 | pubmed:author | pubmed-author:MitsuhashiJun... | lld:pubmed |
| pubmed-article:19414346 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19414346 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:19414346 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19414346 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19414346 | pubmed:pagination | 1059-65 | lld:pubmed |
| pubmed-article:19414346 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:meshHeading | pubmed-meshheading:19414346... | lld:pubmed |
| pubmed-article:19414346 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19414346 | pubmed:articleTitle | Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling. | lld:pubmed |
| pubmed-article:19414346 | pubmed:affiliation | Division of Chemotherapy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo 105-8512, Japan. | lld:pubmed |
| pubmed-article:19414346 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19414346 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
